MetaCap

Who Owns Coherus Oncology Stock?

NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.3698-0.0173 (-4.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
37.22%
Institutional holders
193
  • Institutions 37.2%
  • Insiders 19.1%
  • Public and other 43.7%

Who owns Coherus Oncology stock?

Institutional investors own about 37.2% of Coherus Oncology's shares, spread across 193 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 19.12% of CHRS.

The largest institutional holders are Timothy G. Youngquist 2020 Irrevocable Trust (16.89%), Blackrock Inc. (15.54%) and Vanguard Capital Management LLC (7.70%). Together, the top 10 institutions control 64.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CHRS positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CHRS

Coherus Oncology top institutional holders
InstitutionShares% HeldChange
Timothy G. Youngquist 2020 Irrevocable Trust26.10M16.89%0.0%
Blackrock Inc.24.01M15.54%+15.8%
Vanguard Capital Management LLC11.90M7.70%+9.1%
Geode Capital Management, LLC7.37M4.77%+18.1%
Samsara BioCapital, LLC6.86M4.44%0.0%
Kohlberg Kravis Roberts & Co. L.P.6.07M3.93%0.0%
State Street Corporation4.76M3.08%+2.4%
Two Sigma Investments, LP4.52M2.92%-1.9%
CM Management, LLC4.20M2.72%0.0%
C WorldWide Group Holding A/S3.86M2.50%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CHRS

Coherus Oncology top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund7.91M5.12%
iShares Trust-iShares Russell 2000 ETF6.54M4.23%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund3.73M2.41%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund2.65M1.72%
BlackRock Funds-BlackRock Advantage Small Cap Core Fund1.86M1.20%
Delaware Group Equity Funds IV-Nomura Healthcare Fund1.80M1.17%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund1.53M0.99%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund1.49M0.97%
iShares Trust-iShares Russell 2000 Value ETF1.49M0.96%
SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF1.41M0.91%

Frequently asked questions

Who is the largest shareholder of Coherus Oncology?

Timothy G. Youngquist 2020 Irrevocable Trust is the largest institutional shareholder of CHRS, owning 16.89% of shares outstanding (26.10M shares) as of its latest 13F filing.

What percentage of Coherus Oncology is owned by institutions?

Institutions own about 37.2% of CHRS shares and 46.0% of the public float.

How much of Coherus Oncology do insiders own?

Insiders, such as officers and directors, own about 19.12% of CHRS shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related